Kezar Life Sciences to Participate in the Jefferies Healthcare Conference
31 May 2023 - 9:00PM
Business Wire
Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage
biotechnology company discovering and developing breakthrough
treatments for immune-mediated and oncologic disorders, today
announced that John Fowler, Co-Founder and Chief Executive Officer,
and Noreen R. Henig, M.D., Chief Medical Officer, will participate
in a fireside chat at the Jefferies Healthcare Conference on
Thursday, June 8, 2023 at 2:00 pm ET in New York, NY.
A webcast of the fireside chat will be available on the “Events
& Presentations” section of the Company’s website at
www.kezarlifesciences.com. Following the event, an archived webcast
will be available on the Kezar website for 90 days.
About Kezar Life Sciences
Kezar Life Sciences is a clinical-stage biopharmaceutical
company discovering and developing novel treatments for
immune-mediated and oncologic disorders. The company is pioneering
first-in-class, small-molecule therapies that harness master
regulators of cellular function to inhibit multiple drivers of
disease via single, powerful targets. Zetomipzomib, its lead
development asset, is a selective immunoproteasome inhibitor that
has completed a Phase 2 clinical trial in lupus nephritis. This
product candidate also has the potential to address multiple
chronic immune-mediated diseases. KZR-261 is the first anti-cancer
clinical candidate from the company’s platform targeting the Sec61
translocon and the protein secretion pathway. An open-label
dose-escalation Phase 1 clinical trial of KZR-261 to assess safety,
tolerability and preliminary tumor activity in solid tumors is
underway. For more information, visit
www.kezarlifesciences.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230531005125/en/
Investor Contact: Gitanjali Jain Vice President, Investor
Relations and External Affairs gjain@kezarbio.com
Media Contact: Julia Deutsch Solebury Strategic
Communications jdeutsch@soleburystrat.com
Kezar Life Sciences (NASDAQ:KZR)
Historical Stock Chart
From Apr 2024 to May 2024
Kezar Life Sciences (NASDAQ:KZR)
Historical Stock Chart
From May 2023 to May 2024